New experimental investigations of phase relations in the Yb2O3–Al2O3andZrO2–Yb2O3–Al2O3systems
浅谈县级药品不良反应监测与日常监管工作相结合的工作模式

县级药品不良反应监测机构是我国药品不良反应监测体系中的重要环节,作用与特点突出。
我国至今还没有在县一级政府建立专职的药品不良反应监测机构,现行的县级药品不良反应监测机构都是县级药品监督管理机构指派一至二名人员兼职负责辖区内的药品不良反应监测工作。
1县级药品不良反应监测机构的状况1.1人员少、兼职多县级药品监管机构的工作人员是按照国家规定比例配置,除去正副局长、工勤人员、办公室人员等后,剩下的监管人员已经不多,同时抽出一至二名监管人员负责药品不良反应的监测工作;而县级药品监管机构监管本身任务重,管理相对人多达400至500家,基本上是一个或者两个科室除了要承担上级主管部门四至六个处室下达的监管任务,还要承担本部门同级政府下派的其他工作任务,由此形成工作时间主抓药作者简介:朱跃勇(1971-),男,本科,主管药师,药品监管。
浅谈县级药品不良反应监测与日常监管工作相结合的工作模式朱跃勇1,王艳春2,王淑芳3(1抚顺县食品药品监督管理局,辽宁抚顺113006;2抚顺市药品不良反应监测中心,辽宁抚顺113006;3抚顺市第四医院,辽宁抚顺113123)中图分类号:R954文献标识码:A 文章编号:1672-8629(2009)05-0305-03摘要:县级药品不良反应监测机构是我国药品不良反应监测体系中的重要环节,作用与特点突出。
抚顺县食品药品监督管理局努力探索县级药品不良反应监测的工作模式,即把药品不良反应的监测工作与日常药品监管工作有机结合起来,完善辖区内药品不良反应体系建设,采取“六个结合”与“五查八对”等办法,有效促进了药品不良反应监测工作的健康发展。
关键词:药品不良反应;监测;监管Discussion on the Combination of Adverse Drug Reaction Monitoring and Drug Supervision ZU Yue-yong 1,WANG Yan-chun 2,WANG Shu-fang 31Fushun Food and Drug Administration (Fushun 113006,China)2Fushun Center for ADR Monitoring (Fushun 113006,China)3The Fourth Hospital of Fushun (Fushun 113123,China)Abstract:Adverse drug reaction (ADR)monitoring in county is the terminal of ADR monitoring system,and has important action.Fushun food and drug administration finds a way suitable for ADR monitoring in county.ADR monitoring in county combined with the drug supervision by improving the construction of adverse reactions system with the "6combination"and "5inspection and 8check"approach.Key words:adverse drug reactions(ADR);monitoring;supervision305品监管、业余时间抓药品不良反应监测及上报工作的局面。
预先危险性分析(PHA)培训ppt课件

危险源的控制 l 事故预防对策的基本要求 l (1)预防生产过程中产生的危险和有害因素; l (2)排除工作场所的危险和有害因素; l (3)处置危险和有害物并减低到国家规定的限值内; l (4)预防生产装置失灵和操作失误产生的危险和有害因素; l (5)发生意外事故时能为遇险人员提供自救条件的要求。
l 该方法是系统安全分析法之一,它主要用于某一项工程的 设计、施工、生产之前,对系统存在的危险性类别,出现 条件,可能导致事故的后果作一概略分析的方法。同时该 方法也是一份实现系统安全危害分析的初步或初始的计划, 是在方案开发初期阶段或设计阶段之初完成的。
3
二、PHA目的
1、识别危险,确定安全性关键部位; 2、评价各种危险的程度; 3、确定安全性设计准则,提出消除或控制危险的措施。
项目 危险 触发
事故 事故 危险 防治
名称 因素 事件 现象 原因 结果 等级 对策
12
五、危险性的辨识与控制
危险源的辨识 l 危险源泛指系统中可导致事故发生的物的危险状态、人的不安
全行为及管理上的缺陷。从本质上讲就是存在能量、有害物质 和能量、有害物质失去控制而导致的意外释放或有害物质的泄 露、散发两方面因素。 l 危险源是导致系统存在危险性的根源。所以,危险性的辨识实 际上就是对危险源的辨识。在辨识过程中,要注意能量转化和 破坏的问题,以及有毒有害物存在的问题。
¡ 令 新改扩建项目在新装置开车前应对所有工艺进行PHA
¡ (筛选性工艺危害评审、项目批准前PHA、开车前的PHA、最终工 艺安全报告)
¡ 在役装置在工艺装置的整个使用寿命期内进行(PHA基准、 PHA 周期)
l 封存装置 l 装置拆除
17
的筛选
析
分析及评价方法-预先危险性分析(PHA)法

分析及评价方法-预先危险性分析(PHA)法(最新版)编制人:__________________审核人:__________________审批人:__________________编制单位:__________________编制时间:____年____月____日序言下载提示:该文档是本店铺精心编制而成的,希望大家下载后,能够帮助大家解决实际问题。
文档下载后可定制修改,请根据实际需要进行调整和使用,谢谢!并且,本店铺为大家提供各种类型的安全管理制度,如通用安全、交通运输、矿山安全、石油化工、建筑安全、机械安全、电力安全、其他安全等等制度,想了解不同制度格式和写法,敬请关注!Download tips: This document is carefully compiled by this editor. I hope that after you download it, it can help you solve practical problems. The document can be customized and modified after downloading, please adjust and use it according to actual needs, thank you!In addition, this shop provides you with various types of safety management systems, such as general safety, transportation, mine safety, petrochemical, construction safety, machinery safety, electrical safety, other safety, etc. systems, I want to know the format and writing of different systems ,stay tuned!分析及评价方法-预先危险性分析(PHA)法为了系统地找出系统中的不安全因素,把系统加以剖析,列出各层次的不安全因素,然后确定检查项目,以提问的方式把检查项目按系统的组成顺序编制成表,以便进行检查或评审,这种表就叫作安全检查表。
2.3预先危险性分析(PHA)

高处坠落
物体打击
挤碰伤人
机械倾翻
机件倾倒
吊物坠落
触发条件
触发条件 人员伤亡 设备损坏
触发条件 人员伤亡 设备损坏
触发条件 人员伤亡 设备损坏
触发条件 人员伤亡 设备损坏
触发条件 人员伤亡 设备损坏
人员伤亡
三级
三级
三级
四级
四级
三级
安全防范措施
9
2. 3预先危险性分析(Preliminary Hazard Analysis,PHA)
较充分的调查了解。然后按系统和子系统一步一步地查找危险性,分析的一般步骤如下: (1)确定范围:明确所分析系统的功能及分析范围。 (2)分析、识别危险性:调查、了解过去的经验和同类生产中的发生过的事故情况,分析对 象出现事故的可能类型,确定危险因素存在于哪个子系统中。调查可采用安全检查表、经验方 法和技术判断的方法。 (3)识别危险转化条件:即研究危险因素转变为危险状态的触发条件和危险状态转变为事故 (或灾害)的必要条件,并进一步谋求防止办法,检验这些办法的效果。 (4)划分危险等级:即把预计到潜在危险性划分危险等级。分级的目的是要排列出先后顺序 和重点,以便优先处理。分级方法和含意为: Ⅰ级:安全的,无人员伤亡或系统损坏。
5
2. 3预先危险性分析(Preliminary Hazard Analysis,PHA)
2.3.2预先危险性分析方法 3.分析格式
6
2. 3预先危险性分析(Preliminary Hazard Analysis,PHA)
2.3.2预先危险性分析方法 4.PHA分析法特点
预先危险性分析是一种应用范围较广(人、机、物、环境等方面的危险
LPR 2002 (2)

Laryngopharyngeal reflux 2002: a new paradigm of airway disease. (Introduction).AbstractOur purpose in writing this supplement is to provide an overview of laryngopharyngeal reflux (LPRencompassing; some of the material presented is controversial; and we recognize that it does represent the bias of physicians at the Center for Voice Disorders of Wake Forest University. Furthermore, we understand that we raise as many questions as we answer. Still, we hope that this supplement will serve as a useful summary of LPR for clinicians, and that it will stimulate others in the research arena.Background) was recognized in antiquity. In 1618, Fabricius described the gastroesophagealjunction, which he referred to as cardiaterm because symptoms arising from the gastroesophageal junction could mimic those arising fromAds by Google Questions on Lung DiseaseFind Instant Answers to All Your Lung Disease Questions on Bing ™.Ask a Feline Vet Online8 Veterinarians Are Online! Ask a Question, Get an Answer ASAP./Cat/Feline(1) for the first half of the 20th century he and his contemporaries did not understand GER. For(3)In 1968, laryngopharyngeal reflux (LPR)--that is, GERD that affects the larynx and pharynx--was described in relationship to contact ulcers and granulomas of the larynx. (4,5) However, relatively fewreflux of gastric contents into the throat, but rather the result of vagally mediated reflexes.together with small dental rubber bands. Published in 1987, preliminary data from patients with clinical LPR who had undergone ambulatory 24-hour double-probe (simultaneous pharyngealthat acid was present in the pharynx of most of these patients. (21)In 1989, Wiener et al reported the results of double-probe pH monitoring in a series of 32 otolaryngology patients with clinical LPR; 78% of them had pH-documented LPR. (22) Analysis of the pH tracings made it apparent that the pattern of reflux in LPR was different from that usually seen in GERD; the LPR patients had predominantly upright (daytime) reflux. (22) This finding was new and surprising, because most patients with GERD had been previously shown to be predominantly supine (nocturnal) refluxers. (1) In addition, fewer than one-third of the LPR patients had esophagitison that the patterns and mechanisms of LPR might be different from those of classic GERD (figure). But the reason LPR patients were upright refluxers without heartburn or esophagitis was still unknown.Areas of ongoing researchMuch of the subsequent LPR research has been focused on seven areas: (1) associations with other diseases, (2) symptoms and findings, (3) mechanisms, (4) neurophysiologic reflexes, (5) diagnostic tests, (6) treatment outcomes, and (7) cell biology.LPR association data. The goal of this type of research is to show the association between certain medical conditions and the presence of LPR by clinical and reflux-testing criteria. (1,23-49)Defining the symptoms and findings of LPR. Many studies have sought to define the clinicalparameters of LPR. (1,50,51)LPR mechanisms. (52-54) Why is LPR different from GERD? Why do LPR patients have upright reflux and not esophagitis or heartburn? How are the mechanisms of LPR different from those of GERD?begun to examine the neurophysiologic mechanisms and pathophysiologyNew diagnostic tests for LPR. Although double-probe pH testing is an excellent diagnostic test, it has its limitations. Since 1997, our laboratory has been working to develop sensitive immunoassays forinexpensive tests for LPR. Other new diagnostic methods (e.g., impedance measurement) are also on the horizon. (60-62)Treatment outcomes. Outcomes data have become increasingly important in clinical medicine. Outcomes studies have been and still are being conducted in LPR. (51)Cell biology. Investigations of the impact of reflux on a cellular level are being conducted. In 1998, an international collaborative research network of basic scientists and clinicians was established.than is esophageal epithelium and that peptic injury can occur at a pH level of 5.0 or more. (63,64)LPR is not GERDDespite discoveries that have yielded a better understanding of LPR and how it differs from GERD, much is still not known. LPR remains controversial, partly because the gastroenterology model of reflux disease (i.e., GERD) does not seem to apply to patients with LPR. The term laryngopharyngeal reflux itself was coined because otolaryngologists wanted a new diagnostic term to designate reflux in otolaryngology patients. The clinical dichotomy of reflux patients who are seen by gastroenterologists and those who are seen by otolaryngologists warrants the use of two different diagnostic designations. Several other terms have been used for LPR in the medical literature (table).The prevalence of GERD and of LPR is unknown, but each has been estimated. Reportedly, 10% of the American population has heartburn on a daily basis, and as many as one-third has it less often. (1) In 1988, we estimated that approximately 10% of patients with laryngeal and voice disorders had LPR.(65) In 2000, a prospective study of 113 patients with laryngeal and voice disorders found that 57 (50%) had pH-documented reflux. (46)A study to determine the prevalence of LPR symptoms and findings in a community-based cohort found that they were common in "normals." (66) The mean age of the 100 volunteers was 60 years, and none of them had a history of reflux disease or took any antireflux medication. However, 35% of these subjects reported one or more LPR symptoms, and 64% had one or more LPR findings on examination.A host of controversies remainsLPR is ubiquitous. If one combines all the clinical and normative data, it would be easy to conclude that at least one-third of the American population older than 40 years has LPR. Although this is speculation, if one combines the potential size of the LPR and GERD populations, as many as 100 million Americans might have reflux. In truth, the epidemiology of LPR and GERD remains to be studied.But who really has LPR? In fact, what is LPR? Is it simply a combination of certain symptoms and findings? How is the diagnosis made? Indeed, there has been controversy about how to diagnosecompare the symptoms of individual patients during the course of treatment. (50) We have also instituted a standardized method of grading the laryngeal findings of LPR, which we call the reflux(51) This tool has proved to be very useful in the diagnosis and treatment of LPR. The RSI and the RFS are both validated outcomes instruments. Based on data obtained from normals, an RSI of more than 10 and an RFS of more than 5 are abnormal. (66)Why is LPR controversial? Not only are the symptoms and findings of LPR not clearcut, more important is the fact that there is no ideal diagnostic test battery for evaluating LPR. Traditional diagnostic criteria for GERD simply do not apply to LPR. Why is a pH value of less than 4.0 defined as a significant reflux event? Do patients with LPR require esophageal screening for esophagitis and other complications? Why do LPR patients require relatively high-dose (twice-daily) treatment withSymptoms. There is no universal agreement on the symptoms of LPR. When is postnasal dripCould the presence of too much mucus in the nose and throat be the result of direct irritation from LPR or the result of vagally mediated responses to throat irritation? What happens to patients with sinus symptoms and LPR when the LPR is effectively controlled?Clinical findings. There is no clear consensus about the findings and clinical manifestations of LPR. Although an extremely high incidence of LPR has been reported in patients with subglottic stenosis,ulcers heal uneventfully? Is it not the inflammation of LPR that likely continues the nonhealing process?)Diagnostic testing. Controversy surrounds diagnostic testing for LPR, including pH monitoring. Howundergo pH monitoring? How is it interpreted? (At our center, we believe that full esophageal manometry of the pharynx and esophageal sphincter is essential in p atients with LPR to ensure accurate pH data. (68) Furthermore, we feel that the proximal probe must be located in the pharynx. We perform ambulatory 24-hour double-probe simultaneous [esophageal and pharyngeal] pH monitoring, with probe placement based on manometric measurement. (69)Interpretation of findings. Interpretation of pharyngeal reflux events is controversial. Should we use a pH level of less than 4.0 as the pH threshold for determining reflux in the pharynx? Is laryngeal epithelium more sensitive to acid and peptic injury than is esophageal epithelium? Significant peptic injury to laryngeal epithelium has been reported in patients whose pH level was 5.0. (64) Would it be appropriate to use a pH level of less than 5.0 as the threshold for determining/measuring pharyngeal reflux? How many reflux events in the pharynx should be considered normal? Does a single positive pharyngeal reflux event not prove the existence of LPR?Treatment. It is interesting that many experienced clinicians have long rec ognized that treatment of LPR must be more intense and prolonged than is treatment for GERD. Indeed, the recently published position statement by the American Academy of Otolaryngology--Head and Neck Surgery on LPR was in part commissioned to provide a patient advocacy position--that is, to support the use of twice-daily proton-pump inhibitor medications in LPR, often for extended periods. (67)Considerations for future researchI personally believe that LPR research will someday present us with a new par adigm of airway disease. Reflux will be shown to dominate the internal environment and thus influence nearly all airway diseases (but obviously not all airway diseases in all patients). Tasker et al recently used aFuture research might show that reflux (of activated pepsin) is an inflammatory catalyst for many airway diseases, including cancers of the larynx, lung, esophagus, and pharynx.Table.Synonyms for 'laryngopharyngeal reflux'Atypical refluxExtraesophagela refluxGastropharyngeal refluxLaryngeal refluxPharyngoesophageal refluxReflux laryngitisSupraesophageal refluxReferences(1.) Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 25-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101 (Suppl 53):1-78.(4.) Cherry J, Margulies SI. Contact ulcer of the larynx. Laryngoscope 1968;78:1937-40.(5.) Delahunty JE, Cherry J. Experimentally produced vocal cord granulomas. Laryngoscope 1968;78:1941-7.Laryngol Otol 1972;86:335-42.(7.) Chodosh PL. Gastro-esophago-pharyngeal reflux. Laryngoscope 1977;87:1418-27.(9.) Ward PH, Zwitman D, Hanson D, Berci G. Contact ulcers and granulomas of the larynx: New insights into their etiology as a basis for more rational treatment. Otolaryngol Head Neck Surg 1980;88:262-9.(10.) Ward PH, Berci G. Observations on the pathogenesis of chronic non-specific pharyngitisLaryngoscope 1982; 92:1377-82.(11.) Orenstein SR, Orenstein DM, Whitington PF. Gastroesophageal reflux causing stridor1983;84:301-2.(12.) Bain WM, Harrington JW, Thomas LE, Schaefer SD. Head and neck manifestations of gastroesophageal reflux. Laryngoscope 1983;93:175-9.(13.) Ohman L, Olofsson J, Tibbling L, Ericsson G. Esophageal dysfunction in patients with contact ulcer of the larynx. Ann Otol Rhinol Laryngol 1983;92:228-30.(14.) Olson NR. Effects of stomach acid on the larynx. Proc Am Laryngol Assoc 1983;104:108-12.(15.) Belmont JR. Grundfast K. Congenital laryngeal stridor (laryngomalacia): Etiologic factors and associated disorders. Ann Otol Rhinol Laryngol 1984:93:430-7.(16.) Feder RJ, Michell MJ. Hyperfunctional, hyperacidic, and intubation granulomas. ArchOtolaryngol 1984;110:582-4.(18.) Little FB, Koufman JA, Kohut RI, Marshall RB. Effect of gastric acid on the pathogenesis of subglottic stenosis. Ann Otol Rhinol Laryngol 1985;94:516-9.(19.) Menon AP, Schefft GL, Thach BT. Apnea associated with regurgitation(20.) Olson NR. The problem of gastroesophageal reflux. Otolaryngol Clin North Am 1986;19:119-33.(21.) Wiener GJ, Koufman JA, Wu WC, et al. The pharyngo-esophageal dual ambulatory pH probe for evaluation of atypical manifestations of gastroesophageal reflux (GER) [abstract]. Gastroenterology 1987;92:1694.(22.) Wiener GJ, Koufman JA, Wu WC, et al. Chronic hoarseness secondary to gastroesophageal reflux disease: Documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol 1989;84:1503-8.(23.) Svensson G, Schalen L, Fex S. Pathogenesis of idiopathic contact granuloma of the larynx. Results of a prospective clinical study. Acta Otolaryngol Suppl 1988;449:123-5.3.(26.) Andze GO, Brandt ML, St. Vil D, et al. Diagnosis and treatment of gastroesophageal reflux in 500 children with respiratory symptoms: The value of pH monitoring. J Pediatr S urg 199l;26:295-300.(27.) Burton DM, Pransky SM, Katz RM, et al. Pediatric airway manifestations of gastroesophageal reflux. Ann Otol Rhinol Laryngol 1992;101:742-9.(28.) Koufman JA. Contact ulcer and granuloma of the larynx. In: Gates GA, ed. Current Therapy in Otolaryngology--Head and Neck Surgery. 5th ed. St. Louis: Mosby, 1994:456-9.(29.) Jindal JR, Milbrath MM, Shaker R, et al. Gastroesophageal reflux disease as a likely cause of "idiopathic" subglottic stenosis. Ann Otol Rhinol Laryngol 1994;103:186-91.paroxysmal (per´ksiz´m l),1996;106:1502-5.(32.) Parsons DS. Chronic sinusitis: A medical or surgical disease? Otolaryngol Clin North Am 1996;29:1-9.(33.) Koufman JA, Burke AJ. The etiology and pathogenesis of laryngeal carcinoma. Otolaryngol Clin North Am 1997;30:1-19.(34.) Little JP, Matthews BL, Glock MS. et al. Extraesophageal pediatric reflux: 24-hourdouble-probepH monitoring in 222 children. Ann Otol Rhinol Laryngol Suppl 1997;169:1-16.(35.) Walner DL, Holinger LD. Supraglottic stenosis in infants and children. A preliminary report. Arch Otolaryngol Head Neck Surg 1997; 123:337-41.(36.) Toohill RJ, Kuhn JC. Role of refluxed acid in pathogenesis of laryngeal disorders. Am J Med 1997;103(5A):100S-106S.(37.) Toohill RJ, Ulualp SO, Shaker R. Evaluation of gastroesophageal reflux in patients with laryngotracheal stenosis. Ann Otol Rhinol Laryngol 1998;107:l0l0-4.(38.) Ross JA, Noordzji JP, Woo P. Voice disorders in patients with suspected laryngo-pharyngeal reflux disease. J Voice 1998;12: 84-8.J Voice 1998;12:89-90.(41.) Gumpert L, Kalach N, Dupont C, Contencin P. Hoarseness and gastroesophageal reflux in children. J Laryngol Otol 1998;112: 49-54.(42.) Halstead LA. Role of gastroesophageal reflux in pediatric upper airway disorders. Otolaryngol Head Neck Surg 1999;120:208-14.(43.) Al-Sabbagh G, Wo JM. Supraesophageal manifestations of gastroesophageal reflux disease. Semin Gastrointest Dis 1999;10: 113-9.(44.) Hanson DG, Jiang JJ. Diagnosis and management of chronic laryngitis associated with reflux. Am J Med 2000;108(Suppl 4a):112S-119S.(45.) Grontved AM, West F. pH monitoring in patients with benign voice disorders. Acta Otolaryngol Suppl 2000;543:229-31.(46.) Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000;123:385-8.(47.) Poelmans J, Tack J, Feenstra L. Chronic middle ear disease and gastroesophageal reflux disease: A causal relation? Otol Neurotol 2001;22:447-50.(48.) Tasker A, Dettmar PW, Panetti M, et al. Reflux of gastric juice and glue ear in children [letter]. Lancet 2002;359:493.(49.) Loehrl TA, Smith TL, Darling RJ, et al. Autonomic dysfunction, vasomotor rhinitis, and extraesophageal manifestations of gastroesophageal reflux. Otolaryngol Head Neck Surg 2002;126: 382-7.(50.) Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice 2002;16:274-7.(51.) Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001;1l1: 1313-7.(53.) Postma GN, Tomek MS. Belafsky PC, Koufman JA. Esophageal motor function in laryngopharyngeal reflux is superior to that in classic gastroesophageal reflux disease. Ann Otol Rhinol Laryngol 2001;ll0:1114-6.(54.) Koufman JA, Belafsky PC, Daniel E, et al. Prevalence of esophagitis in patients with pH-documented laryngopharyngeal reflux. Laryngoscope 2002;112:1606-9.(55.) Loughlin CJ, Koufman JA, Averill DB, et al. Acid-induced laryngospasm in a canine model. Laryngoscope 1996;106:1506-9.(56.) Duke SG, Postma GN, McGuirt WF, Jr., et al. Laryngospasm and diaphragmatic arrest in(57.) Sekizawa S, Ishikawa T, Sant'Ambrogio FB, Sant' Ambrogio G. Vagal esophageal receptors in(58.) Ishikawa T, Sekizawa SI, Sant' Ambrogio FB, Sant' Ambrogio G. Larynx vs. esophagus as reflexogenic sites for acid-induced bronchoconstriction in dogs. J Appl Physiol 1999;86:1226-30.(59.) Sant' Ambrogio FB, Sant' Ambrogio G, Chung K. Effects of HCI-pepsin laryngeal instillations on upper airway patency-maintaining mechanisms. J Appl Physiol 1998;84:1299-304.-metry: An evolving technique to measure type and proximal extent of gastroesophageal reflux. Am J Med 2001;111(Suppl 8A):157S-159S.(61.) Srinivasan R, Vela MF, Katz PO, et al. Esophageal function testing using multichannel intraluminal impedance. Am J Physiol Gastrointest Liver Physiol 2001;280:G457-62.Surg 2001;13:255-64.(63.) Axford SE, Sharp N, Ross PE, et al. Cell biology of laryngeal epithelial defenses in health and disease: Preliminary studies. Ann Otol Rhinol Laryngol 2001;110:1099-1108.(64.) Johnson N, Bulmer D, Gill G, et al. Cell biology of laryngeal epithelial defenses in health and disease: Preliminary studies (Part II). Submitted for publication.The diagnostic role of 24-hour pH monitoring. J Voice 1988;2:78-89.(66.) Reulbach TR, Belafsky PC, Blalock PD, et al. Occult laryngeal pathology in a community-based cohort. Otolaryngol Head Neck Surg 2001;124:448-50.(67.) Koufman JA, Aviv JE, Casiano RR, Shaw GY. Laryngopharyngeal reflux: Position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology--Head and Neck Surgery. Otolaryngol Head Neck Surg 2002;127:32-5.(68.) Johnson PE, Koufman JA, Nowak LJ, et al. Ambulatory 24-hour double-probe pH monitoring: The importance of manometry. Laryngoscope 2001;111:1970-5.(69.) Johnson PE, Amin MA, Postma GN, et al. pH monitoring in patients with laryngopharyngeal reflux (LPR): Why the pharyngeal probe is essential. Submitted for publication.。
PHA培训课件

PHA培训课件
contents
目录
• PHA概述 • PHA基础知识 • PHA实践案例 • PHA应用中的常见问题及解决方案 • 如何提高PHA技能 • PHA未来发展趋势
01
PHA概述
定义与特点
Polyhyd…
一种由微生物合成的可生物降解 的生物聚酯,具有多种特性,如 生物相容性、生物可降解性、无 毒性等。
详细描述
模型选择问题包括模型类型选择不当、模型参数设置不合理、模型训练过度等情况。为解决这些问题,需要根 据实际问题和数据特征选择合适的模型,并对模型进行充分的验证和评估。同时,需要根据模型特点和数据特 征设置合适的参数,避免模型训练不足或过度的情况。
结果解读问题
总结词
PHA应用中模型训练和预测的结果需要准 确和清晰地解读,才能为决策提供科学依 据。
06
PHA未来发展趋势
PHA技术的不断发展
技术的不断完善
PHA技术正在不断完善,不断提高生产效率和降低成本,使 其更具竞争力。
新的应用领域
随着技术的不断发展,PHA的应用领域也将越来越广泛,涉 及到医疗、能源、环保等多个领域。
PHA与其他领域的交叉融合
与生物医药的融合
PHA与生物医药的融合,将为医疗领域提供更加安全、有效的医疗用品和药 物。
组织工程
PHA可作为生物相容性良好的组织 工程支架材料,用于人工器官和组 织的制造。
02
PHA基础知识
PHA基本原理
01
PHA是英文“Phylogenetic Comparative Analysis”的缩写,即系统发育比较 分析。
02
PHA利用物种之间的进化关系来比较它们的特征,从而推断这些特征的进化历 史和相互关系。
PHA(讲义杜邦培训课程)

建立PHA监控机制,通过定期巡查、数据分析等方式,及时发现潜在风险并采 取相应的应对措施。
03 现场实践案例分 析
典型事故案例剖析
案例一
某化工厂爆炸事故。通过对此事 故进行深入剖析,详细阐述事故 发生的原因、过程和后果,引导 学员理解事故背后的安全隐患和
管理漏洞。
案例二
某油库泄漏事故。分析事故原因 ,探讨如何预防类似事故的发生 ,并介绍相关的应急处理措施。
PHA在更多领域的应用
预测PHA将在更多领域得到应用,如智能制造、医疗健康等,为 这些领域提供更全面、深入的风险管理支持。
PHA与其他技术的融合
探讨PHA与其他技术,如人工智能、大数据等的融合应用,以提高 风险管理的效率和准确性。
PHA的持续发展和创新
展望PHA在未来的持续发展和创新,包括新的理论、方法和技术的 研究和应用。
预防措施制定及实施计划
预防措施制定
根据风险评估结果,制定相应的预防 措施,如技术改进、操作规程修改、 安全培训等。
实施计划
明确预防措施的实施时间、责任人、 所需资源等,确保措施得以有效执行 。
持续改进策略及监控方法
持续改进策略
定期对PHA实施效果进行评估,针对存在的问题和不足制定改进措施,实现安 全管理的持续改进。
06 总结回顾与展望 未来
关键知识点总结回顾
1 2
PHA的基本原理和核心概念
包括PHA的定义、作用、实施步骤等关键知识点 。
PHA的常用工具和技术
介绍常用的PHA工具和技术,如头脑风暴、故障 树分析、事件树分析等。
3
PHA在风险管理中的应用
阐述PHA在识别、评估和控制风险方面的应用, 以及与其他风险管理工具的结合使用。
PHA培训材料PPT课件

在某个特定装置的生命周期里不太可能发生, 但有多个类似装置时,可能在其中的一个里发 10到10 -2-3 生
在装置的生命周期内可能至少发生一次
-2
>10
36
五、PHA分析结果的风险评估(续)
3、风险定级
F-4 IV II I
I
可 F-3 IV III II
I
能
性 级
F-2
IV
IV
III
的详细设计应由指定完成建议任务的人员落实。)
39
六、建议的提出回复和关闭(续)
2、回复建议 直线领导对建议的回复方式: ➢ 接受建议和指派责任人和规定完成时间。 ➢ 修改建议和指派责任人和规定完成时间。 ➢ 拒绝建议(必须将拒绝的原因记录在案并附在PHA报告
后)。 3、关闭建议 一旦直线组织领导对建议作出回复,建议即关闭
风险 = 事件的严重性 x 可能 性
1、严重性(后果)评估
35
五、PHA分析结果的风险评估(续)
2、可能性评估
简单的可能性评估矩阵
类别
典型的描述
近似的相应量化频率 (每年)
F-1
现实中预期不会发生
极不可能
-4
<10
F-2 一般不可能
预期不会发生,但一旦发生也不是不可想象的
10到10
-3-4
F-3 可能
1严重性后果评估风险事件的严重性x可能性35类别典型的描述近似的相应量化频率每年f1极不可能现实中预期不会发生410f2一般不可能预期不会发生但一旦发生也不是不可想象的3410到10f3可能在某个特定装置的生命周期里不太可能发生但有多个类似装置时可能在其中的一个里发生2310到10f4很可能在装置的生命周期内可能至少发生一次210五pha分析结果的风险评估续2可能性评估简单的可能性评估矩阵36f4iviiiif3iviiiiiif2iviviiiiif1iviviviiic1c2c3c4五pha分析结果的风险评估续后果级别可能性级别3风险定级37风险等级描述需要的行动pha改进建议i不能容忍的应当立即落实工程和或管理上的控制措施并立即进行整改整改期限不得超过6个月最终把风险降低到级别iii或以下
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
∗
Corresponding author. Tel.: +49 3731 3931il address: fabrich@ww.tu-freiberg.de (O. Fabrichnaya).
it should be mentioned that Yb3 Al5 O12 phase with garnet structure has good optical properties and presents interest for laser application [6,7]. The Yb2 O3 –Al2 O3 system is also of interest because of possible application of directionally solidified eutectics [8]. The Yb3 Al5 O12 (YbAG) phase was also suggested as new thermal barrier coating material [9]. The investigation performed in the present paper is aimed to investigate phase relations in the ZrO2 –Yb2 O3 –Al2 O3 system and assess thermodynamic parameters of this system. The Al2 O3 is the main component of thermally grown oxide (TGO) forming during thermal cycling of TBC. The derived thermodynamic database can be used for modelling interface reactions between top coat of TBC and (TGO). Interaction of multiple co-doped YSZ with Al2 O3 is important to estimate stability of TBC during thermal cycling. The ZrO2 –Yb2 O3 –Al2 O3 system is one of the constituent system of the ZrO2 –RE2 O3 –Yb2 O3 –Y2 O3 –Al2 O3 system (RE = La, Nd, Sm, Gd) which is important for developments of new TBC materials. Phase relations in the ZrO2 –Yb2 O3 –Al2 O3 system were experimentally studied and different phase diagram such as
Available online at
ScienceDirect
Journal of the European Ceramic Society 35 (2015) 2855–2871
New experimental investigations of phase relations in the Yb2O3–Al2O3 and ZrO2–Yb2O3–Al2O3 systems and assessment of thermodynamic parameters
O. Fabrichnaya a,∗ , S.M. Lakiza b , M.J. Kriegel a , J. Seidel c , G. Savinykh a , G. Schreiber a
a
Institute of Materials Science, Technical University Bergakademie Freiberg, Gustav-Zeuner Str. 5, D-09599 Freiberg, Germany b Frantsevich Institute for Problems of Materials Science, NASU, Krzhizhanovsky Str. 3, 03142 Kiev, Ukraine c Institute Physical Chemistry, Technical University Bergakademie Freiberg, Leipziger Str. 29, D-09599 Freiberg, Germany Received 12 March 2015; received in revised form 26 March 2015; accepted 29 March 2015 Available online 18 April 2015
Keywords: Phase diagrams; Electron microscopy; X-ray methods; Thermal analysis; Thermodynamic modelling
1. Introduction The co-doping of Y2 O3 stabilised zirconia (YSZ) by Yb increases oxygen conductivity [1,2] and stability of YSZ against transformation to monoclinic phase [3]. Additionally, Yb co-doping improves mechanical properties of YSZ [4] and decreases its thermal conductivity [3]. Therefore Yb co-doped YSZ is of interest for such applications as oxygen sensors, solid state electrolytes and thermal barrier coating (TBC). The effects of reduction of thermal conductivity and increase of phase stability important for TBC application can be enhanced by multiple co-doping of YSZ with two cations one larger (i.e. Sm, Nd, La) and other smaller (i.e. Yb, Sc) than Y. Such co-doping leads to nano-scale clustering of the smaller and larger cations with uniformly distributed Y cations contributes to phonon scattering and therefore to thermal conductivity reduction [5]. Additionally
/10.1016/j.jeurceramsoc.2015.03.037 0955-2219/© 2015 Elsevier Ltd. All rights reserved.
2856
O. Fabrichnaya et al. / Journal of the European Ceramic Society 35 (2015) 2855–2871
Abstract Phase relations were experimentally studied in the Yb2 O3 –Al2 O3 and ZrO2 –Yb2 O3 –Al2 O3 systems. Samples were prepared from oxide mixture and by co-precipitation. Phase equilibria were studied in the range 1523–2023 K and investigated by XRD and SEM/EDX. Heat capacity of the Yb3 Al5 O12 (YbAG) phase was measured between 293 and 1473 K by DSC. Phase transformations and melting relations were investigated by DTA up to 2373 K. The stability range of Yb4 Al2 O9 (YbAM) phase was determined to be between 1923 and 2186 K. The character of its melting was determined from crystallisation microstructure and DTA as peritectic. The thermodynamic parameters of the Yb2 O3 –Al2 O3 system were derived based on obtained results. Melting relations in the ternary system were studied experimentally. Based on the data obtained a thermodynamic description for the ternary system was derived. The new experimental study of the ZrO2 –Yb2 O3 system is recommended to get better fit of experimental data in ternary system. © 2015 Elsevier Ltd. All rights reserved.